A 7-yr-old girl with high density lipoprotein (HDL) deficiency and xanthomas has been identified in a Turkish kindred with repetitive consanguinity. She has severely reduced HDL-cholesterol and no apolipoprotein (apo) A-I. ApoA-II is reduced, whereas apoA-IV and apoC-III are normal. ApoB and low density lipoprotein (LDL)-cholesterol are increased. This is reflected in hypercholesterolemia. VLDL and IDL particles are low, and serum triglycerides are normal. The genetic defect could be identified as a base insertion into the third exon of the apoA-I gene. This leads to a nonsense peptide sequence beginning at amino acid 5 of the mature plasma protein and early termination of translation. The patient is homozygous for this mutation. Pedigree analysis indicated an autosomal dominant inheritance with no evidence of another genetic defect of lipoprotein metabolism in the kindred. In HDL deficiency, HDL binding to leukocytes was increased compared to normal. In the postprandial state, binding of labeled HDL3 to leukocytes is unchanged. This is in contrast to results with postprandially isolated leukocytes from controls or Tangier patients, which have a reduced binding capacity for HDL3. These results indicate that postprandial HDL precursors may compete the binding of labeled HDL3. The metabolic consequences of HDL deficiency were analyzed. There is only a small number of HDL-like particles containing apoA-II, apoA-IV, apoE, and lecithin/cholesteryl acyl transferase. The C-apolipoproteins were normal in the proband. Due to the lack of HDL they can only associate with apoB-containing particles, where they may interfere with cellular uptake. Thus, pure apoA-I deficiency leads to a complex metabolic derangement.
K J Lackner, H Dieplinger, G Nowicka, G Schmitz
Title and authors | Publication | Year |
---|---|---|
Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia.
Busnelli M, Manzini S, Colombo A, Franchi E, Bonacina F, Chiara M, Arnaboldi F, Donetti E, Ambrogi F, Oleari R, Lettieri A, Horner D, Scanziani E, Norata GD, Chiesa G |
Arteriosclerosis, thrombosis, and vascular biology | 2022 |
Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1
PE Khoury, P Couvert, S Elbitar, Y Ghaleb, Y Abou-Khalil, Y Azar, C Ayoub, A Superville, M Guérin, JP Rabès, M Varret, C Boileau, S Jambart, P Giral, A Carrié, WL Goff, M Abifadel |
Journal of Clinical Lipidology | 2018 |
Genetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice
SA Wiltshire, E Diez, Q Miao, MP Dubé, M Gagné, O Paquette, RG Lafrenière, M Ndao, LW Castellani, E Skamene, SM Vidal, A Fortin |
Physiological genomics | 2012 |
Complete Apo AI Deficiency in an Iraqi Mandaean Family: Case studies and review of the literature
A Al-Sarraf, K Al-Ghofaili, DR Sullivan, KM Wasan, R Hegele, J Frohlich |
Journal of Clinical Lipidology | 2010 |
The HDL Handbook
NJ Hime |
The HDL Handbook | 2010 |
Atlas of Atherosclerosis and Metabolic Syndrome
SM Grundy |
2010 | |
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia
L Pisciotta, T Fasano, L Calabresi, A Bellocchio, R Fresa, C Borrini, S Calandra, S Bertolini |
Atherosclerosis | 2008 |
Characterization of lecithin:cholesterol acyltransferase expressed in a human lung cell line
SB Lane, KT Tchedre, MP Nair, AE Thigpen, AG Lacko |
Protein Expression and Purification | 2004 |
High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions
P Barter, J Kastelein, A Nunn, R Hobbs |
Atherosclerosis | 2003 |
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency
L Pisciotta, R Miccoli, A Cantafora, L Calabresi, P Tarugi, P Alessandrini, GB Bon, G Franceschini, C Cortese, S Calandra, S Bertolini |
Atherosclerosis | 2003 |
Atlas of Atherosclerosis
PW Wilson |
2003 | |
Biochemie und Pathobiochemie
G Löffler, PE Petrides |
2003 | |
Quantitative trait locus mapping of genes that regulate HDL cholesterol in SM/J and NZB/B1NJ inbred mice
WA Pitman, R Korstanje, GA Churchill, E Nicodeme, JJ Albers, MC Cheung, MA Staton, SS Sampson, S Harris, B Paigen |
Physiological genomics | 2002 |
Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients
M Melter, B Rodeck, R Kardorff, PF Hoyer, C Petersen, A Ballauff, J Brodehl |
The American Journal of Gastroenterology | 2000 |
Compound Heterozygosity for an Apolipoprotein A1 Gene Promoter Mutation and a Structural Nonsense Mutation With Apolipoprotein A1 Deficiency
A Matsunaga, J Sasaki, H Han, W Huang, M Kugi, T Koga, S Ichiki, T Shinkawa, K Arakawa |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency
D Sich, Y Saı̈di, P Giral, L Lagrost, J Dallongeville, MC Federspiel, C Cherfils, A Raisonnier, G Turpin, I Beucler |
Atherosclerosis | 1998 |
Continuous free-flow electrophoresis
L Křivánková, P Boček |
Electrophoresis | 1998 |
Apolipoprotein A-I Zavalla (Leu 159 →Pro): HDL Cholesterol Deficiency in a Kindred Associated With Premature Coronary Artery Disease
M Miller, D Aiello, H Pritchard, G Friel, K Zeller |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
A Novel Homozygous Missense Mutation in the Apo A-I Gene With Apo A-I Deficiency
W Huang, J Sasaki, A Matsunaga, H Nanimatsu, K Moriyama, H Han, M Kugi, T Koga, K Yamaguchi, K Arakawa |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
Analytical capillary isotachophoresis of human serum lipoproteins
G Schmitz, C Möllers, V Richter |
Electrophoresis | 1997 |
Apolipoprotein A-I Fin: Dominantly Inherited Hypoalphalipoproteinemia Due to a Single Base Substitution in the Apolipoprotein A-I Gene
HE Miettinen, H Gylling, TA Miettinen, J Viikari, L Paulin, K Kontula |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Apolipoprotein A-I FIN (Leu159→Arg) Mutation Affects Lecithin: Cholesterol Acyltransferase Activation and Subclass Distribution of HDL but Not Cholesterol Efflux From Fibroblasts
HE Miettinen, M Jauhiainen, H Gylling, S Ehnholm, A Palomäki, TA Miettinen, K Kontula |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I
TP Leren, KS Bakken, U Daum, L Ose, K Berg, G Assmann, A von Eckardstein |
Journal of lipid research | 1997 |
Retinopathy and Neuropathy Associated With Complete Apolipoprotein A-l Deficiency
DS Ng, PW OConnor, CB Mortimer, LA Leiter, PW Connelly, RA Hegele |
The American Journal of the Medical Sciences | 1996 |
Retinopathy and Neuropathy Associated With Complete Apolipoprotein A-I Deficiency:
DS Ng, PW O'Connor, CB Mortimer, LA Leiter, PW Connelly, RA Hegele |
The American Journal of the Medical Sciences | 1996 |
Compound Heterozygosity for a Structural Apolipoprotein A-I Variant, Apo A-I(L141R) Pisa , and an Apolipoprotein A-I Null Allele in Patients With Absence of HDL Cholesterol, Corneal Opacifications, and Coronary Heart Disease
R Miccoli, A Bertolotto, R Navalesi, L Odoguardi, A Boni, J Wessling, H Funke, H Wiebusch, A von Eckardstein, G Assmann |
Circulation | 1996 |
A Cysteine-Containing Truncated Apo A-I Variant Associated With HDL Deficiency
K Moriyama, J Sasaki, Y Takada, A Matsunaga, J Fukui, JJ Albers, K Arakawa |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Peripheral Blood Mononuclear Phagocyte Subpopulations as Cellular Markers in Hypercholesterolemia
G Rothe, H Gabriel, E Kovacs, J Klucken, J Stöhr, W Kindermann, G Schmitz |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Molecular Reviews in Cardiovascular Medicine
K Lindpaintner, D Ganten |
1996 | |
Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation?
EC Quintão |
Atherosclerosis | 1995 |
Structural models of human apolipoprotein A-I
C Brouillette |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1995 |
The low down on lipoprotein lipase
H Funke, G Assmann |
Nature Genetics | 1995 |
Reverse Cholesterol Transport in Plasma of Patients With Different Forms of Familial HDL Deficiency
A von Eckardstein, Y Huang, S Wu, H Funke, G Noseda, G Assmann |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Apolipoprotein A-I Deficiency: Biochemical and Metabolic Characteristics
DS Ng, C Vezina, TS Wolever, A Kuksis, RA Hegele, PW Connelly |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease
K Takata, K Saku, T Ohta, M Takata, H Bai, S Jimi, R Liu, H Sato, G Kajiyama, K Arakawa |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Severe Familial HDL Deficiency in French-Canadian Kindreds: Clinical, Biochemical, and Molecular Characterization
M Marcil, B Boucher, L Krimbou, BC Solymoss, J Davignon, J Frohlich, J Genest |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Recent concepts of lipoprotein pathophysiology
G Schonfeld |
Atherosclerosis | 1994 |
A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas
R Römling, A von Eckardstein, H Funke, C Motti, GC Fragiacomo, G Noseda, G Assmann |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |